PT Kalbe Farma Tbk. (IDX:KLBF)
Indonesia · Delayed Price · Currency is IDR 995.00
+15.00 (1.53%)
Apr 15, 2026, 11:05 AM WIB
PT Kalbe Farma Tbk. Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,664,998 | 3,240,637 | 2,766,748 | 3,382,210 | 3,183,621 |
Depreciation & Amortization | 788,375 | 736,294 | 711,362 | 704,491 | 664,206 |
Other Amortization | 25,818 | 24,681 | 19,612 | 35,725 | 29,611 |
Other Operating Activities | -1,208,536 | 783,567 | -589,627 | -2,850,537 | -1,051,492 |
Operating Cash Flow | 3,270,655 | 4,785,179 | 2,908,096 | 1,271,889 | 2,825,946 |
Operating Cash Flow Growth | -31.65% | 64.55% | 128.64% | -54.99% | -33.06% |
Capital Expenditures | -725,801 | -907,909 | -881,551 | -705,458 | -503,910 |
Sale of Property, Plant & Equipment | 208,052 | 41,038 | 14,916 | 8,668 | 21,451 |
Cash Acquisitions | -332,880 | -181,725 | - | -691,070 | -64,000 |
Divestitures | 13,200 | 19,084 | - | - | - |
Sale (Purchase) of Intangibles | -73,547 | -312,862 | -278,441 | -145,324 | -488,845 |
Investment in Securities | -65,304 | -34,895 | -110,095 | 120,105 | -128,826 |
Other Investing Activities | 176,388 | 129,981 | 114,384 | 47,309 | 108,111 |
Investing Cash Flow | -799,892 | -1,247,288 | -1,140,787 | -1,370,390 | -1,056,019 |
Short-Term Debt Issued | 814,738 | 884,777 | 1,746,293 | 1,453,200 | 136,100 |
Long-Term Debt Issued | - | 125,640 | 227,600 | - | - |
Total Debt Issued | 814,738 | 1,010,417 | 1,973,893 | 1,453,200 | 136,100 |
Short-Term Debt Repaid | -971,488 | -741,307 | -2,331,093 | -945,600 | -356,600 |
Long-Term Debt Repaid | -138,321 | -361,036 | -215,898 | -187,663 | -312,694 |
Total Debt Repaid | -1,109,809 | -1,102,343 | -2,546,991 | -1,133,263 | -669,294 |
Net Debt Issued (Repaid) | -295,071 | -91,926 | -573,098 | 319,937 | -533,194 |
Issuance of Common Stock | - | 3,089 | - | - | - |
Repurchase of Common Stock | -842,087 | -460,485 | - | -1,001,910 | - |
Common Dividends Paid | -1,635,802 | -1,433,930 | -1,757,714 | -1,631,320 | -1,312,443 |
Other Financing Activities | -96,320 | -108,653 | -113,795 | -92,460 | 1,100,460 |
Financing Cash Flow | -2,869,280 | -2,091,905 | -2,444,607 | -2,405,754 | -745,177 |
Foreign Exchange Rate Adjustments | 6,663 | 44,887 | -40,050 | 237,776 | -16,433 |
Net Cash Flow | -391,854 | 1,490,873 | -717,348 | -2,266,479 | 1,008,318 |
Free Cash Flow | 2,544,854 | 3,877,270 | 2,026,545 | 566,431 | 2,322,036 |
Free Cash Flow Growth | -34.37% | 91.32% | 257.77% | -75.61% | -29.52% |
Free Cash Flow Margin | 7.20% | 11.88% | 6.66% | 1.96% | 8.84% |
Free Cash Flow Per Share | 55.90 | 83.95 | 43.81 | 12.18 | 49.54 |
Cash Interest Paid | 43,272 | 61,961 | 91,495 | 53,591 | 66,572 |
Cash Income Tax Paid | 1,008,591 | 910,734 | 985,600 | 1,152,778 | 965,742 |
Levered Free Cash Flow | 2,509,022 | 3,170,000 | 1,262,874 | -725,102 | 1,268,018 |
Unlevered Free Cash Flow | 2,531,052 | 3,205,199 | 1,314,722 | -699,336 | 1,296,446 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.